Skip to main content

Table 3 Subgroup univariate analysis of sexual functioning in GCT survivors treated with orchiectomy only versus with chemotherapy containing ≥400 mg/m2 of cisplatin or < 400 mg/m2 of cisplatina

From: Long-term sexual functioning in germ-cell tumor survivors

   N Mean SEM Median P value
Sexual desire AS 17 3.29 0.21 3 NA
< 400 51 3.31 0.14 3 0.94
≥400 80 3,05 0.09 3 0.23
  N Mean SEM Median P value
Attempts to initiate intercourse AS 17 2.41 0.39 2 NA
< 400 51 2.61 0.25 3 0.65
≥400 80 2.38 0.18 2 0.91
  N Mean SEM Median P value
Achieve erection AS 17 4.47 0.42 5 NA
< 400 51 4.12 0.22 5 0.55
≥400 80 3.90 0.19 5 0.17
  N Mean SEM Median P value
Maintain erection AS 17 4.47 0.41 5 NA
< 400 51 3.84 0.23 5 0.16
≥400 80 3.78 0.18 4 0.06
  N Mean SEM Median P value
Achieve orgasm AS 17 4.65 0.38 5 NA
< 400 50 4.34 018 5 0.37
≥400 80 3.97 0.17 5 0.03
  N Mean SEM Median P value
Disappointed with quality of sex life AS 17 1.35 0.22 1 NA
< 400 50 1.52 0.11 1 0.67
≥400 79 1.65 0.10 1 0.24
  N Mean SEM Median P value
Anxiety from sexual relationships AS 17 1.41 0.21 1 NA
< 400 50 1.24 0.09 1 0.23
≥400 79 1.48 0.09 1 0.97
  N Mean SEM Median P value
Strong desire to be sexually active AS 17 2.88 0.26 3 NA
< 400 50 2.88 0.15 3 0.98
≥400 79 2.76 0.11 3 0.63
  1. Abbreviations: AS Active surveillance, < 400 - chemotherapy containing < 400 mg/m2 of cisplatin,
  2. ≥400 - chemotherapy containing ≥400 mg/m2 of cisplatin, SEM – standard error of the mean, NA – not applicable
  3. aone patient receiving VAB VAI regimen was excluded from this analysis